All In Biotech

Free tool

FAERS Monitor: Wakix

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211150 or its brand name (Wakix, Pitolisant Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,117

Serious

1,013

48% of reports

Hospitalization

247

Death reported

10

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea245
  • drug ineffective239
  • anxiety235
  • headache222
  • insomnia221
  • product administration interrupted203
  • somnolence190
  • product dose omission issue186
  • fatigue184
  • dizziness125
  • middle insomnia125
  • depression116
  • surgery113
  • feeling abnormal103
  • vomiting97

Reports by year received

View as table
YearReports
20157
201617
20177
201820
201939
2020496
2021158
2022240
2023294
2024444
2025272
2026123

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,042 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product administration interruptedSignal203263.7231.051,525
middle insomniaSignal12567.056.58,009
surgerySignal11319.216.01,931
somnolenceSignal1909.48.21,427
insomniaSignal2218.27.31,418
anxietySignal2358.27.31,500
product dose omission issueSignal1866.35.5833
depressionSignal1165.14.2379
feeling abnormalSignal1034.33.5258
headacheSignal2223.53.1410
nauseaSignal2453.12.7354
dizzinessSignal1252.52.1113
fatigueSignal1842.32.0146
vomitingSignal972.01.752
drug ineffective2391.81.690

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.